Literature DB >> 29656904

Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.

Timucin Taner1, Michael P Gustafson2, Michael J Hansen3, Walter D Park4, Svetlana Bornschlegl2, Allan B Dietz2, Mark D Stegall5.   

Abstract

Kidney allografts of patients who undergo simultaneous liver-kidney transplantation incur less immune-mediated injury, and retain better function compared to other kidney allografts. To characterize the host alloimmune responses in 28 of these patients, we measured the donor-specific alloresponsiveness and phenotypes of peripheral blood cells after the first year. These values were then compared to those of 61 similarly immunosuppressed recipients of a solitary kidney or 31 recipients of liver allografts. Four multicolor, non-overlapping flow cytometry protocols were used to assess the immunophenotypes. Mixed cell cultures with donor or third party cells were used to measure cell proliferation and interferon gamma production. Despite a significant overlap, simultaneous liver-kidney transplant recipients had a lower overall frequency of circulating CD8+, activated CD4+ and effector memory T cells, compared to solitary kidney transplant recipients. Simultaneous liver-kidney transplant recipient T cells had a significantly lower proliferative response to the donor cells compared to solitary kidney recipients (11.9 vs. 42.9%), although their response to third party cells was unaltered. The frequency of interferon gamma producing alloreactive T cells in simultaneous liver-kidney transplant recipients was significantly lower than that of solitary kidney transplant recipients. Flow cytometric analysis of the mixed cultures demonstrated that both alloreactive CD4+ and CD8+ compartments of the simultaneous liver-kidney transplant recipient circulating blood cells were smaller. Thus, the phenotypic and functional characteristics of the circulating blood cells of the simultaneous liver-kidney transplant recipients resembled those of solitary liver transplant recipients, and appear to be associated with donor-specific hypo-alloresponsiveness.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  alloimmunity; immunoregulation; kidney transplantation; rejection; simultaneous liver-kidney transplantation

Mesh:

Substances:

Year:  2018        PMID: 29656904     DOI: 10.1016/j.kint.2018.01.022

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients.

Authors:  Masahiko Yazawa; Orsolya Cseprekal; Ryan A Helmick; Manish Talwar; Vasanthi Balaraman; Pradeep S B Podila; Sallyanne Fossey; Sanjaya K Satapathy; James D Eason; Miklos Z Molnar
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

2.  Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies.

Authors:  Arnaud Del Bello; Olivier Thaunat; Moglie Le Quintrec; Oriol Bestard; Antoine Durrbach; Peggy Perrin; Philippe Gatault; Frederic Jambon; Georges-Philippe Pageaux; Laura Llado; Camille Besch; Louise Barbier; Martine Neau-Cransac; Jérôme Dumortier; Nassim Kamar
Journal:  Kidney Int Rep       Date:  2020-10-03

3.  Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair.

Authors:  LaTonya J Hickson; Alfonso Eirin; Sabena M Conley; Timucin Taner; Xiaohui Bian; Ahmed Saad; Sandra M Herrmann; Ramila A Mehta; Travis J McKenzie; Todd A Kellogg; James L Kirkland; Tamar Tchkonia; Ishran M Saadiq; Hui Tang; Kyra L Jordan; Xiangyang Zhu; Mathew D Griffin; Andrew D Rule; Andre J van Wijnen; Stephen C Textor; Lilach O Lerman
Journal:  Diabetes       Date:  2021-04-15       Impact factor: 9.337

Review 4.  Crossmatch, Donor-specific Antibody Testing, and Immunosuppression in Simultaneous Liver and Kidney Transplantation: A Review.

Authors:  Anushka Das; Timucin Taner; Jim Kim; Juliet Emamaullee
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

5.  Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning.

Authors:  Jason P Cooper; James D Perkins; Paul R Warner; Alexandra Shingina; Scott W Biggins; Janis L Abkowitz; Jorge D Reyes
Journal:  Liver Transpl       Date:  2021-11-05       Impact factor: 6.112

Review 6.  Strategies for Liver Transplantation Tolerance.

Authors:  Filip Cvetkovski; J Mark Hexham; Erik Berglund
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

7.  Comparable in vitro Function of Human Liver-Derived and Adipose Tissue-Derived Mesenchymal Stromal Cells: Implications for Cell-Based Therapy.

Authors:  Furkan Yigitbilek; Sabena M Conley; Hui Tang; Ishran M Saadiq; Kyra L Jordan; Lilach O Lerman; Timucin Taner
Journal:  Front Cell Dev Biol       Date:  2021-03-26

Review 8.  Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function.

Authors:  Yikang Li; Zhengrui You; Ruqi Tang; Xiong Ma
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

Review 9.  Significance of progressive liver fibrosis in pediatric liver transplants: A review of current evidence.

Authors:  Mathew George; Philippe Paci; Timucin Taner
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

10.  Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.

Authors:  Nobuhisa Akamatsu; Kiyoshi Hasegawa; Seisuke Sakamoto; Hideki Ohdan; Ken Nakagawa; Hiroto Egawa
Journal:  Transplant Direct       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.